Skip to content
Danaher Corp

DHR

Danaher Corp

Danaher Corp historical holders

total: 15

ValueAct Holdings Danaher Corp transactions over time

Total transactions:
3
New positions:
1
Sold out:
1
Added:
1
Held since:
2023 Q3
Held for:
2 quarters
Latest activity:
2024 Q1
Jeffrey Ubben has been an institutional investor in Danaher Corp (DHR) since 2023 Q3. According to 2026 Q2 report, Jeffrey Ubben doesn't hold any shares. The fund/company first acquired DHR in 2023 Q3, initially purchasing 118,000 shares. Since the initial investment, ValueAct Holdings has made 2 more transactions in this position.

When did Jeffrey Ubben exit their DHR position?

Jeffrey Ubben no longer holds Danaher Corp (DHR). They sold off their entire position in 2024 Q1, closing out an investment that began in 2023 Q3.

When did Jeffrey Ubben first invest in DHR?

Jeffrey Ubben first invested in Danaher Corp (DHR) in 2023 Q3 at the reported quarter-end price of $248.10 per share, acquiring 118,000 shares in their initial purchase.

What is Jeffrey Ubben's average cost basis for DHR?

Based on historical transaction data, Jeffrey Ubben's estimated cost basis for Danaher Corp (DHR) is approximately $241.23 per share. This represents their average reported price* across all buy transactions.

Estimated cost basis*

Weighted AVG buy price:
$241.23
Weighted AVG sell price:
$231.34

DHR transactions history by ValueAct Holdings

3 results
Period % of
portfolio
Shares
held after*
Reported
price*
Value* % (shares)
of activity
% change
to portfolio
2024 Q1
0.00%
0
$231.34
-100% (-200,000)
-0.93%
2023 Q4
0.93%
200,000
$231.34
$46,268,000
+69.49% (+82,000)
+0.38%
2023 Q3
0.66%
118,000
$248.10
$29,275,800
new
+0.66%
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.